Veterinary Pain Management Market By Sources Analysis, Share, Trends, Size, Forecast From 2024-2032

Veterinary Pain Management Market Valuation – 2024-2031

The growing awareness and emphasis on animal welfare has considerably increasing the demand for effective pain management solutions. Pet owners are becoming more informed and proactive about their pets’ health, looking for innovative therapies to ensure their animals’ comfort and quality of life is propelling the market growth to surpass USD 1.66 Billion in 2024 and reach USD 3.44 Billion by 2031.

The veterinary pain treatment industry is being driven largely by advances in veterinary medicine, including the introduction of new analgesics, anti-inflammatory medicines, and alternative therapies such as acupuncture and laser therapy. These innovations provide more effective and diverse pain management solutions for animals, treating both acute and chronic problems. As a result, pet owners and veterinarians are increasingly adopting these innovative treatments to improve the health and quality of life of animals, driving market growth is expected to grow at a CAGR of about 9.53% from 2024 to 2031.

Veterinary Pain Management Market: Definition/ Overview

Veterinary pain management refers to the procedures and treatments used to relieve pain in animals, assuring their comfort and quality of life. It covers a wide range of applications, including the use of analgesics, anti-inflammatory medicines, physical therapies, and alternative treatments such as acupuncture and laser therapy to manage pain caused by injuries, operations, chronic illnesses, and other health issues.

The future of veterinary pain treatment seems positive, because to continued advances in veterinary medicine, increased emphasis on animal welfare, and rising demand for specialized pain management options. Pharmaceutical innovations, non-invasive therapies, and individualized pain management programs are likely to improve treatment effectiveness and extend the market, making comprehensive pain management more accessible and effective for all animals.

Will Increasing Prevalence of Painful and Inflammatory Diseases in Animal is Driving the Veterinary Pain Management Market?

The growing prevalence of painful and inflammatory disorders in animals is fueling the veterinary pain management market. The growth in illnesses such as arthritis, cancer, and post-surgical pain in pets and cattle demands appropriate pain treatment strategies. Because of increased veterinary treatment, animals are living longer lives and are more prone to acquire chronic and age-related illnesses that necessitate continuing pain management. The increasing need for appropriate treatment options for various illnesses drives the demand for sophisticated veterinary pain management treatments.

Arthritis is a frequent chronic ailment that affects older pets, especially dogs and cats. As pets age, they frequently experience joint discomfort and inflammation, limiting their mobility and quality of life. Effective pain management, including the use of nonsteroidal anti-inflammatory medications (NSAIDs), vitamins, and physical therapies, is critical in keeping these animals healthy and comfortable. The desire for such medicines has prompted greater research and development in veterinary pharmaceuticals, with the goal of providing more effective and safe solutions for treating arthritis and other inflammatory illnesses in pets.

Cancer is another painful ailment affecting a large number of animals. Pain management in cancer-stricken pets is crucial for their well-being during therapy and palliative care. The development of pain management techniques, including as opioid analgesics, nerve blocks, and new pharmacological regimens, has become a priority in veterinary cancer. As the prevalence of cancer in animals increases, so does the demand for comprehensive pain treatment solutions, which is driving the veterinary pain management market. Veterinary specialists are constantly looking for novel and improved ways to relieve pain in animals undergoing cancer treatment, driving up market demand.

Post-surgery pain management is an important feature of veterinary treatment, particularly as surgical procedures for pets become more widespread. Procedures ranging from simple spaying and neutering to major orthopedic procedures necessitate excellent pain management to ensure a quick recovery and minimal suffering. Advances in anesthesia and postoperative pain management approaches, such as the use of local anesthetics, epidurals, and multimodal analgesia, are critical to improving surgical outcomes in veterinary patients. As more pet owners choose surgical methods to address various health conditions in their animals, the demand for effective pain management in post-surgery care grows, driving the veterinary pain management market.

Rising activities by the government and other organizations are also predicated to a favorable impact on the market. For Instance, in October 2020, FECAVA launched a campaign titled “FECAVA Basic Practices in Anesthesia and Analgesia,” which includes important lectures throughout Europe in the coming years as well as a series of six ready-to-use, printable posters/infographics on anesthesia and pain management in animals. Such supportive activities are projected to open up new potential for the market in the coming years.

Will Growing Stringent Regulatory Process Hinder the Growth of the Veterinary Pain Management Market?

Growing strict regulatory processes may impede the growth of the veterinary pain treatment market by raising the time and expense associated with bringing novel pain management medications to market. Veterinary medications are subject to severe approval standards from regulatory authorities such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These regulations are intended to assure the safety, efficacy, and quality of pharmaceuticals, but they can also provide substantial challenges for pharmaceutical companies. The lengthy and costly clearance procedure may inhibit innovation and postpone the launch of new pain treatment methods, limiting market growth.

The intensive testing and clinical trials required for novel veterinary pain management medications are governed by strict standards. These trials must show that the products are both safe for animals and effective in pain management. The procedure consists of various stages, including laboratory research, preclinical studies, and clinical trials, which might take several years to complete. The significant expenses connected with these trials might be prohibitive, especially for smaller businesses and startups. As a result, some breakthrough products may never reach the market, limiting veterinarians and pet owners’ access to new and effective pain management solutions.

Furthermore, regulatory compliance does not stop with the approval of a product. Continuous monitoring and reporting are also required to assure ongoing safety and efficacy. This includes pharmacovigilance operations including adverse reaction monitoring and periodic safety evaluations. These post-market surveillance measures can be resource-intensive, requiring substantial financial and administrative commitments. Companies must commit significant efforts to comply with these rules, which can divert funding away from research and development of new products, further impeding market growth.

Also, the variation in regulatory requirements across areas can complicate the process for businesses looking to market their products globally. Each country or region may have its own set of regulations and regulatory processes, which can make it more difficult for businesses to expand their market reach. Navigating these complicated regulatory landscapes necessitates significant expertise and expenditure, which can prove difficult for many businesses. This variety might cause delays in product releases and limit the availability of veterinary pain management solutions in specific markets, affecting the global veterinary pain management market’s overall growth.

Category-Wise Acumens

Will Rising Widespread Use of Analgesic and Anti-inflammatory Drugs Drive the Veterinary Pain Management Market?

The increasing general use of analgesic and anti-inflammatory medications is propelling the veterinary pain treatment market. These drugs are vital for treating a wide range of pain-related disorders in animals, including acute injuries and surgical recuperation, as well as chronic diseases like arthritis and cancer. Analgesics, which include opioids and non-opioid pain medicines, provide excellent pain relief, whereas nonsteroidal anti-inflammatory drugs (NSAIDs) assist reduce inflammation and relieve pain caused by a variety of illnesses. The rising prevalence of these painful and inflammatory illnesses in pets and livestock has resulted in increased demand for these drugs, driving market expansion.

The growing use of analgesic and anti-inflammatory medications reflects a greater understanding among pet owners and veterinarians of the relevance of pain management in animal health and wellbeing. As pet ownership grows worldwide, more owners are looking for holistic care for their animals, including efficient pain management methods. Veterinarians are also becoming more aggressive in detecting and treating animal pain, realizing that untreated pain can have a substantial influence on an animal’s quality of life and general health. This increased awareness is boosting the usage of a wide range of pain management medications, hence promoting market growth.

Furthermore, advances in veterinary pharmaceuticals have resulted in the creation of new and improved analgesic and anti-inflammatory medications, hence improving their efficacy and safety profiles. Long-acting pain medications, combination therapy, and tailored drug delivery devices are among the innovations that veterinarians are using to effectively manage animal pain. These innovations not only improve treatment outcomes, but also lessen the adverse effects of traditional pain drugs, making them more appealing to pet owners. Continuous improvement and diversification of pain management medications contribute to the veterinary pain management market’s long-term growth.

Additionally, the regulatory climate has become more favorable to the development and approval of veterinary pain management medications. Regulatory organizations, such the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have set precise rules for approving novel veterinary drugs, assuring their safety and efficacy. This legislative assistance encourages pharmaceutical companies to spend in the research and development of innovative pain treatment options, therefore growing the market. As regulatory frameworks evolve, the availability of a wider choice of effective and safe pain management medications is projected to support growth in the veterinary pain management market.

The Devices section, which includes products like laser therapy devices, acupuncture needles, and pain management implants, is the fastest growing. This rapid growth is being driven by increased use of non-pharmacological pain management treatments, advances in veterinary medical technology, and a growing desire for holistic and least invasive treatment alternatives among pet owners and veterinarians.

Will Increasing Hospitals and Clinics Fuel the Veterinary Pain Management Market?

The growing number of hospitals and clinics specializing in veterinary care are expected to significantly fuel the veterinary pain management industry. These facilities play an important role in delivering complete animal healthcare services, such as diagnostics, operations, and continuing pain-management. As the need for specialised veterinary services increases, so does the need for effective pain management solutions to maintain the comfort and well-being of pets and animals.

Veterinary hospitals and clinics are increasingly equipped with new medical technologies and specialized skills, enabling for more precise diagnosis and treatment of animal pain. These clinics provide a wide range of pain management alternatives, from standard pharmacological treatments like analgesics and anti-inflammatory medicines to novel therapies like acupuncture, physical therapy, and laser therapy. This holistic strategy not only treats acute and chronic pain, but also promotes rehabilitation and long-term management techniques.

Furthermore, the growth of veterinary-focused hospitals and clinics reflects a broader trend toward greater animal health and welfare standards. Pet owners are increasingly seeking specialist medical treatment for their animals, owing to a rising understanding of veterinary medicine developments and the value of preventative healthcare. This shift in consumer behavior has resulted in increasing investment in veterinary facilities and services, expanding the availability and accessibility of pain management treatments.

The COVID-19 pandemic has also expedited the uptake of veterinary services, such as pain management, as pet owners prioritize their animals’ health and well-being. The epidemic highlighted the significance of providing accessible and dependable healthcare for pets, causing many veterinary practices to broaden their offers and capabilities. This includes telemedicine services, which are increasingly used to give remote consultations and medicines, improving convenience and accessibility for pet owners looking for pain treatment solutions.

The retail outlets section, which includes veterinary pharmacy and pet stores, is the most rapidly growing. This expansion is being driven by the increased availability of over-the-counter pain treatment drugs, improved accessibility for pet owners, and the convenience of obtaining medications and therapies directly from retail outlets.

Gain Access into Veterinary Pain Management Market Report Methodology

Country/Region-wise

Will Rising Pet Adoption in North America Drive the Veterinary Pain Management Market?

Rising pet adoption in North America is a major force driving the veterinary pain management market. The rise in pet ownership has resulted in increased demand for veterinary services, particularly pain management. As more homes adopt dogs, the demand for complete healthcare, including pain management for injuries, chronic ailments, and procedures, grows. This increase in pet ownership is mostly driven by a growing perception of pets as family members, which has led to a greater desire among pet owners to spend in their animals’ health and well-being.

Increasing pet adoption is linked to a higher frequency of chronic illnesses like arthritis, which are frequent in older pets. As pets age, they frequently need continual pain care to preserve their quality of life. As a result, the need for medications such analgesics and anti-inflammatory treatments increases. Veterinary clinics and hospitals are reacting to this need by increasing their pain management services, including innovative treatments and therapies to meet the different needs of pets. This growth is fueled by ongoing advances in veterinary medicine, which offer more effective and safer pain management solutions.

In addition to chronic illnesses, the rise in pet adoption has increased the frequency of elective and essential surgical procedures. Surgery, from spaying and neutering to more complex orthopedic treatments, necessitates efficient postoperative pain management to promote a quick recovery and minimize discomfort. The increasing number of pets receiving such treatments adds to the demand for veterinary pain management products and services. Veterinary practitioners are increasingly using multimodal pain management approaches that include medicines, physical therapy, and alternative treatments to provide holistic care and enhance outcomes.

Increasing per capita animal healthcare expenditure in North America is propelling the veterinary pain management industry. As pet owners devote more resources to their pets’ health and well-being, there is an increased need for advanced veterinarian treatments, such as effective pain management options. This increased investment enables the adoption of newer, more advanced treatments and technologies to manage animal pain, ranging from pharmaceuticals to alternative therapies, hence driving market growth and assuring improved healthcare results for pets.

Will Increasing Awareness of Animal Health and Welfare in Asia-Pacific Propel the Veterinary Pain Management Market?

The growing awareness of animal health and welfare in the Asia-Pacific region is driving the veterinary pain management industry. This expanding awareness is being driven by a number of causes, including more pet ownership, a greater acceptance of pets as family members, and the influence of worldwide movements that emphasize animal rights and care. As more individuals in Asia-Pacific countries recognize the value of excellent pet care, the demand for veterinary services, particularly pain management, is increasing significantly.

Increasing awareness is driven by rising disposable income and changing lifestyles in many Asia-Pacific countries. As urbanization develops and more people and families enter the middle and upper income groups, they are more ready to pay for high-quality pet care. This includes routine veterinarian examinations, immunizations, and pain management treatments for both acute and chronic injuries. The trend of seeing pets as important family members has resulted in a readiness to invest in complete pain management treatments to assure their pets’ comfort and well-being.

Furthermore, educational initiatives and animal health awareness campaigns are helping to boost the regional veterinary pain management market. Governments, non-governmental organizations (NGOs), and veterinary associations are putting more emphasis on educating pet owners about the need of timely and effective pain management. These efforts include workshops, seminars, and media campaigns that highlight animal pain symptoms and treatment choices. As a result, pet owners are becoming more informed and proactive in obtaining veterinarian treatment for their animals, increasing demand for pain management products and services.

Also, the increasing availability and accessibility of modern veterinary care in Asia-Pacific is driving market expansion. The expansion of veterinary clinics and hospitals, together with the advent of advanced diagnostic and therapeutic technology, is improving the ability to manage animal pain effectively. Minimally invasive operations, sophisticated imaging techniques, and holistic pain management approaches, such as acupuncture and laser therapy, are becoming increasingly popular. This improved availability to high-quality veterinary care is resulting in better pain management results for pets and animals, which is driving market growth.

Competitive Landscape

The competitive landscape of the veterinary pain management market is characterized by intense competition and innovation, with numerous companies vying to develop and offer advanced pain management solutions for animals. This market is driven by increasing pet ownership, rising awareness of animal health, and advancements in veterinary care. Various pharmaceutical companies, biotech firms, and specialized veterinary medicine providers are focusing on developing new analgesics, anti-inflammatory drugs, and alternative therapies such as acupuncture and laser therapy. Additionally, there is a growing emphasis on personalized pain management plans tailored to individual animals’ needs, supported by diagnostic tools and technologies. Research and development efforts are robust, with many firms seeking to create more effective and safer pain management options, addressing both acute and chronic pain in pets and livestock. The market is also seeing a surge in collaborations and partnerships aimed at expanding product portfolios and enhancing market reach, alongside regulatory advancements that support innovation and approval of new treatments.

Some of the prominent players operating in the veterinary pain management market include:

• Zoetis, Inc.
• Merial (Sanofi)
• Elanco Animal Health
• Bayer
• Merck & Co.
• Pfizer, Inc.
• Ceva Santé Animale
• Boehringer Ingelheim

Latest Developments

• In November 2023, Krka has launched Robexera, the first generic robenacoxib solution for treating pain and inflammation in dogs with chronic osteoarthritis (OA) and soft tissue surgery. Robexera is a COX2 NSAID formulation that provides anti-inflammatory pain treatment with a once-daily dose regimen. The medicine is supplied as a flavored chewable tablet to make administration easier for pet owners.
• In May 2023, Zoetis, Inc. (NYSE:ZTS) announced that the U.S. Food and Drug Administration (FDA) has approved Librela™ (bedinvetmab injectable) for the treatment of pain associated with OA in dogs. Librela is the first and only once-monthly anti-NGF monoclonal antibody treatment for canine OA pain, and it has been authorized as safe and effective in providing long-term control of OA pain symptoms in dogs, potentially improving their mobility and general quality of life.

Report Scope

Veterinary Pain Management Market, By Category

 Product:

• Drugs
• Devices

Application:

• Osteoarthritis
• Joint Pain
• Postoperative Pain
• Cancer

Anim